Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Sana Biotechnology, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- −4 vs. Q3 2022
- Shares held
- 128.4M
- +90.8K (+0.1%) vs. Q3 2022
- Total value
- $507.0M
- −$262.5M (−34.1%) vs. Q3 2022
- New holders
- 13
- 41 more added
- Sold out
- 17
- 32 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SANA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $644.7M |
| Q1 2026 | 203 | $473.1M |
| Q4 2025 | 203 | $648.8M |
| Q3 2025 | 178 | $581.8M |
| Q2 2025 | 155 | $396.9M |
| Q1 2025 | 161 | $250.6M |
| Q4 2024 | 164 | $257.4M |
| Q3 2024 | 155 | $638.8M |
| Q2 2024 | 148 | $810.3M |
| Q1 2024 | 154 | $1.46B |
| Q4 2023 | 132 | $508.1M |
| Q3 2023 | 136 | $493.5M |
| Q2 2023 | 123 | $804.1M |
| Q1 2023 | 120 | $427.4M |
| Q4 2022 | 120 | $507.0M |
| Q3 2022 | 125 | $769.7M |
| Q2 2022 | 116 | $807.5M |
| Q1 2022 | 117 | $985.8M |
| Q4 2021 | 105 | $1.73B |
| Q3 2021 | 88 | $2.48B |
| Q2 2021 | 80 | $1.93B |
| Q1 2021 | 78 | $3.10B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Sana Biotechnology, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 724,625 | $2.86M | 0.00% | +287,018+65.6% | Added |
| Northern Trust Corp | 780,646 | $3.08M | 0.00% | −9,869−1.2% | Reduced |
| Omega Fund Management, LLC | 843,750 | $3.33M | 1.12% | 00.0% | Unchanged |
| Citadel Advisors LLC | 851,803 | $3.36M | 0.00% | −335,609−28.3% | Reduced |
| Ally Bridge Group (NY) LLC | 1,015,273 | $4.01M | 3.90% | +280,023+38.1% | Added |
| Massachusetts Financial Services Co | 1,052,572 | $4.16M | 0.00% | +234,549+28.7% | Added |
| Geode Capital Management, LLC | 1,808,364 | $7.14M | 0.00% | +109,863+6.5% | Added |
| Goldman Sachs Group Inc | 1,864,498 | $7.36M | 0.00% | +453,630+32.2% | Added |
| JPMorgan Chase & Co | 2,376,002 | $9.38M | 0.00% | −3,710−0.2% | Reduced |
| Alphabet Inc. | 2,812,500 | $11.1M | 0.65% | 00.0% | Unchanged |
| Crestline Management, LP | 3,365,624 | $13.3M | 1.95% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 4,264,492 | $16.8M | 0.00% | +623,989+17.1% | Added |
| Public Sector Pension Investment Board | 6,400,000 | $25.3M | 0.20% | 00.0% | Unchanged |
| State Street Corp | 6,788,751 | $26.8M | 0.00% | +240,669+3.7% | Added |
| BlackRock Inc. | 7,785,351 | $30.8M | 0.00% | +824,894+11.9% | Added |
| Vanguard Group Inc | 8,966,635 | $35.4M | 0.00% | +126,754+1.4% | Added |
| FMR LLC | 9,169,410 | $36.2M | 0.00% | −37,275−0.4% | Reduced |
| Canada Pension Plan Investment Board | 10,175,000 | $40.2M | 0.07% | 00.0% | Unchanged |
| Baillie Gifford & Co | 10,764,727 | $42.5M | 0.04% | −202,009−1.8% | Reduced |
| Flagship Pioneering Inc. | 34,239,018 | $135.2M | 4.32% | 00.0% | Unchanged |
| LMR Partners LLP | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −225,732−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −134,854−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −95,550−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −67,970−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −51,500−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −48,411−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −39,347−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −29,180−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −21,778−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −11,585−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −10,475−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −9,733−100.0% | Sold out |
| Global Trust Asset Management, LLC | 0 | $0 | 0.00% | −298−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −276−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −234−100.0% | Sold out |
| CPWM, LLC | – | – | – | – | Not filed |